A lexicon of DNA modifications: their roles in embryo development and the germline by Zhu, Qifan et al.
REVIEW
published: 27 March 2018
doi: 10.3389/fcell.2018.00024
Frontiers in Cell and Developmental Biology | www.frontiersin.org 1 March 2018 | Volume 6 | Article 24
Edited by:
Patrick McGowan,
University of Toronto, Canada
Reviewed by:
Gerd Peter Pfeifer,
Van Andel Institute, United States
Maurizio D’Esposito,
Consiglio Nazionale delle Ricerche
(CNR), Italy
*Correspondence:
Ramiro Alberio
ramiro.alberio@nottingham.ac.uk
Specialty section:
This article was submitted to
Epigenomics and Epigenetics,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 20 November 2017
Accepted: 27 February 2018
Published: 27 March 2018
Citation:
Zhu Q, Stöger R and Alberio R (2018)
A Lexicon of DNA Modifications: Their
Roles in Embryo Development and the
Germline. Front. Cell Dev. Biol. 6:24.
doi: 10.3389/fcell.2018.00024
A Lexicon of DNA Modifications:
Their Roles in Embryo Development
and the Germline
Qifan Zhu, Reinhard Stöger and Ramiro Alberio*
School of Biosciences, University of Nottingham, Nottingham, United Kingdom
5-methylcytosine (5mC) on CpG dinucleotides has been viewed as the major epigenetic
modification in eukaryotes for a long time. Apart from 5mC, additional DNA modifications
have been discovered in eukaryotic genomes. Many of these modifications are thought
to be solely associated with DNA damage. However, growing evidence indicates that
some base modifications, namely 5-hydroxymethylcytosine (5hmC), 5-formylcytosine
(5fC), 5-carboxylcytosine (5caC), and N6-methadenine (6mA), may be of biological
relevance, particularly during early stages of embryo development. Although abundance
of these DNA modifications in eukaryotic genomes can be low, there are suggestions
that they cooperate with other epigenetic markers to affect DNA-protein interactions,
gene expression, defense of genome stability and epigenetic inheritance. Little is still
known about their distribution in different tissues and their functions during key stages of
the animal lifecycle. This review discusses current knowledge and future perspectives of
these novel DNA modifications in the mammalian genome with a focus on their dynamic
distribution during early embryonic development and their potential function in epigenetic
inheritance through the germ line.
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INTRODUCTION
5-methylcytosine (5mC) in CpG dinucleotides is the most abundantly modified DNA base in
eukaryotes. Its role as an epigenetic regulator of gene expression has been widely studied and
documented (Holliday and Pugh, 1975; Riggs, 1975; Sager and Kitchin, 1975; Bird andWolffe, 1999;
Bird, 2002; Robertson, 2005; Jones, 2012; Smith andMeissner, 2013; Edwards et al., 2017). However,
DNA modifications are much more diverse than previously thought. Apart from 5mC, nearly 40
verified and many more unverified DNA modifications can be found in a newly established DNA
modification Database (Sood et al., 2016). Novel approaches have been suggested for systematic
detection (Thiaville et al., 2016) and computational identification (Iyer et al., 2013) of novel
epigenetic marks in prokaryotes, of which the strategies could also be applied to eukaryotic
genomes. Most of the DNAmodifications are indicators of DNA damage and related to DNA repair
pathways (Ito and Kuraoka, 2015), but they have not yet been correlated with other biological
processes. Studies in the last few years provide growing evidence for biological significance of
some DNA modifications, including 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC),
5-carboxylcytosine (5caC), 5-hydroxymethyluracil (5hmU), and N6-methadenine (6mA). With
recently suggested biological potentials, these DNA base variants are considered as ‘novel DNA
modifications’. The rareness and instability of these novel DNA modifications in eukaryotic
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genomes are the major obstacles for studying their potential
functions. Because of these features, most of the aforementioned
novel modifications were considered to be intermediates of
DNA demethylation processes, and doubts have been cast
on whether they are abundant or sufficiently stable to have
significant effects on biological processes. Whether and how
these novel DNAmodifications can be stably maintained through
cell division and during differentiation is largely unknown.
Still, these modifications have been suggested to cooperate
with histone modifications and thereby affect the epigenome
at specific loci. They also affect the structure and accessibility
of DNA, which in turn regulates DNA-protein interactions,
gene expression and genome stability. Although little is known
about their distribution, their turnover and their functions, these
novel DNA modifications show highly temporal and spatially
restricted profiles. For example, 6mA shows significant but
transient enrichment in early embryogenesis of zebrafish and
pig, with a maximum of ∼0.1% 6mA/A in 32-cell to 64-cell
embryo stage in zebrafish and ∼0.17% in pig 4-cell to morula
stage, but only 0.006% in zebrafish 512-cell stage and 0.05% in
pig blastocyst (Liu J. et al., 2016). Distributions and regulatory
mechanisms of DNA modifications also differ greatly among
species (Law and Jacobsen, 2010; He Y.-F. et al., 2011). For
example, compared to mammalian genomes, a higher proportion
(over 30%) of 5mC in plant genomes is located within non-CG
sites (Vanyushin and Ashapkin, 2011), whereas C. elegans and
D. melanogaster genomes are largely devoid of 5mC (Capuano
et al., 2014). Similar to other well-studied epigenetic marks,
novel DNA modifications are highly dynamic during the two
waves of global epigenetic reprogramming at early embryonic
stages in mammals. However we still know very little about
their roles during these events. This review will discuss the
current knowledge and future perspectives of these novel DNA
modifications as well as 5mC, with a focus on their profiles and
potential biological function in early embryonic development
and the germline in mammals.
5mC AND TET-MEDIATED ACTIVE
DEMETHYLATION IN EARLY
DEVELOPMENT
The presence of 5-methylcytosine in DNA (5mC) was first
reported in mammals in the late 1940s and its role in epigenetic
regulation of gene expression has been widely studied and
documented (Jones, 2012; Plongthongkum et al., 2014; Breiling
and Lyko, 2015). The functions of 5mC in early development
are mainly revealed via studies of 5mC distribution and activities
of its modifiers in embryonic stem cells (ESCs). 5mC in
promoter regions—upstream of transcription start sites (TSS)—
and transposable elements, is generally considered as a silencing
mark for gene expression, while the regulatory role of 5mC on
gene bodies for gene expression remains unclear (Jones, 2012;
Kim et al., 2014; Chen et al., 2016; Hargan-Calvopina et al.,
2016). DNA methylation at distal regulatory elements, such as
embryonic stem cell (ES)-specific enhancers and insulators, has
also been suggested to correlate with gene expression (Hon
et al., 2013; Aran et al., 2016; Heyn et al., 2016) as well as with
the activities of transcriptional regulators (Stadler et al., 2011;
Wang et al., 2012; Maurano et al., 2015; Aran et al., 2016; Hnisz
et al., 2016). For example, triple-knockout (TKO) of Tet (Ten-
eleven translocation) enzymes, the 5mC ‘editors’, in mouse ESCs
(mESCs) results in increased DNA methylation mainly at distal
enhancer regions coupled with changed expression of linked
genes, suggesting that Tet-dependent active demethylation could
participate in the regulation of distal regulatory regions (Hon
et al., 2014; Lu et al., 2014).
In mammals, two waves of epigenetic reprogramming
featuring global DNA demethylation take place in
preimplantation embryos and primordial germ cells
(PGCs). This genome-wide DNA demethylation involves
inhibition of the 5mC-maintenance DNA methyltransferase 1
(Dnmt1)/Ubiquitin-Like with PHD and Ring Finger Domains 1
(Uhrf1) enzyme complex and ‘de novo’ DNA methyltransferases
3a/b (Dnmt3a/b), followed by dilution of 5mC during DNA
replication; a process also known as passive demethylation.
Active, enzyme-mediated ‘methyl-group’ removal mechanism(s),
in which 5mC is oxidized sequentially via Tet proteins into 5-
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and
5-carboxylcytosine (5caC), are also critical for epigenetic
reprogramming.
Global Demethylation in Preimplantation
Embryo
In mice, soon after fertilization, male and female pronuclei show
differential demethylation kinetics (Mayer et al., 2000; Oswald
et al., 2000). These observations have led to a model for DNA
demethylation in which the male pronucleus undergoes active
demethylation mediated by Tet3 (Iqbal et al., 2011). 5hmC
and other oxidative products generated by TET proteins are
removed via the base excision repair (BER) pathway as well
as replication-dependent dilution (Gu et al., 2011; Inoue and
Zhang, 2011; Iqbal et al., 2011). In contrast slower demethylation
kinetics are observed in the maternal pronucleus where histone
H3Lys9-dimethylation marked chromatin (H3K9me2) has a
tighter association with protein Stella/DPPA3 compared to the
paternal pronucleus. This chromatin state has been suggested
to protect the maternal pronucleus from active, Tet3-mediated
demethylation (Nakamura et al., 2007, 2012; Messerschmidt,
2012). The finding that Tet3 predominantly localizes on paternal
pronuclei further supports this model (Gu et al., 2011; Nakamura
et al., 2012). Bisulfite sequencing and mass spectrometry have
also shown pronounced demethylation in the zygote with
different demethylation kinetics between paternal and maternal
pronuclei (Guo F. et al., 2014; Okamoto et al., 2016). However,
investigations at single-base-resolution show that Tet-mediated
demethylation is operational in the maternal genome, albeit with
slower kinetics compared to the paternal genome (Guo F. et al.,
2014; Guo H. et al., 2014; Tsukada et al., 2015; Zhu et al., 2017).
While global demethylation persists until the late blastocyst
stage (Okamoto et al., 2016), Tet3 expression rapidly diminishes
at the 2-cell stage (maternal-zygotic transition) and is replaced
by Tet1/2 around the morula stage (Gu et al., 2011; Iqbal
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et al., 2011; Cao et al., 2014; Lee K. et al., 2014; Gao et al.,
2017). Genome-wide methylation is restored in late blastocysts
and continues during germ layer establishment (Inoue and
Zhang, 2011; Guenatri et al., 2013). During this developmental
stage, Dnmt3a/b exhibit distinct sequence preferences and target
diverse genomic regions (Okano et al., 1999; Watanabe et al.,
2002; Chen et al., 2004; Borgel et al., 2010; Velasco et al.,
2010; Auclair et al., 2014; Liao et al., 2015), while Dnmt3l acts
as cofactor (Ooi et al., 2007; Jurkowska et al., 2011). Overall,
remodeling of the embryonic methylome has been suggested
to be a double-check security system, in which the global
demethylation contributes to the establishment of totipotency
and prevents any potentially deleterious epigenetic inheritance,
while the re-establishment of methylation is crucial for exit of
totipotency/pluripotency and for efficient spatiotemporal control
of genome activity and lineage decision (Guenatri et al., 2013; Lee
H. J. et al., 2014).
A recent study suggested that in the mouse paternal
genome Tet3 may function as an antagonist to de novo
methylation activity in later zygotic stages, but is not necessarily
required for demethylation before pronuclear stage 3 (PN3),
as Tet3-independent 5mC erasure occurs before 5hmC is
generated (Amouroux et al., 2016). Although Tet3-mediated
active demethylation has been linked with paternal genome
activation and activities of pluripotent genes such as Oct4
and Nanog (Ito et al., 2010; Guo F. et al., 2014), deletion of
maternal Tet3 (Gu et al., 2011) does not seem to affect pre-
implantation development. This suggests that Tet3 functions
may be compensated by the other two Tet enzymes, or defects
in DNA active demethylation can be tolerated during pre-
implantation development. Heterozygous Tet3-KO mice show
neonatal sub-lethality, suggesting that Tet3 disruption at early
embryonic stages may affect later development (Gu et al., 2011;
Inoue et al., 2015; Tsukada et al., 2015). It is possible that
passive demethylation on the paternal genome is sufficient for
preimplantation development. That is, partial impairment of
symmetric maintenance DNA methylation at CpG dyads, rather
than active demethylation, is thought to be the main driver of
DNA demethylation of both paternal andmaternal genome at the
zygote stage and also in PGCs (Guo H. et al., 2014; Arand et al.,
2015).
DNA methylation dynamics have also been studied in species
other than mouse. Although the demethylation profiles in
human and mice are generally similar (Smith et al., 2014),
differences have been observed between the 2-cell to morula
stages, such as an increase of methylation level at pronuclear
stage and 4- to 8-cell stages in human embryo (Guo H. et al.,
2014; Zhu et al., 2018). In humans rapid demethylation and
hydroxymethylation are also observed in both male and female
pronuclei, suggesting TET-mediated active demethylation on
both the paternal and maternal genome (Guo H. et al., 2014).
Similar to mouse (Salvaing et al., 2012; Li et al., 2016), 5mC
and 5hmC co-exist in both pronuclei of human zygotes and
in oocytes in a non-reciprocal pattern (Petrussa et al., 2016),
which is consistent with the detection of de novo methylation at
PN3 (Amouroux et al., 2016). In Rhesus monkey, a methylation
peak was also reported at 8-cell stage, and de novo methylation
was observed at some paternal and maternal CpG sites at
2-cell stage and onwards. Single-cell DNA methylome data
of preimplantation human embryo further indicates de novo
methylation is enriched for major families of repetitive elements,
especially evolutionarily younger subfamilies, such as ALU and
LINE1 retroelements (Zhu et al., 2018). These data indicate
that, unlike the generally unidirectional demethylation suggested
before, de novo methylation could be concurrent with and even
‘outpace’ DNA demethylation in preimplantation stages (Gao
et al., 2017). It will be interesting to elucidate the mechanisms
that support these transient waves of DNAmethylation and their
importance for normal development.
DNA methylation and hydroxymethylation profiling in early
embryos of domestic animals, including bovine (Dobbs et al.,
2013), porcine (Cao et al., 2014; Lee K. et al., 2014), ovine
(Jafarpour et al., 2017; Masala et al., 2017), and equine (Heras
et al., 2017), have mainly been reported via immunochemistry,
separating 5mC and 5hmC at limited resolution. Although
active demethylation is not observed in the maternal pronucleus,
it has been reported in the paternal pronucleus of pig (Cao
et al., 2014; Lee K. et al., 2014). Both paternal and maternal
pronuclei in bovine show 5hmC signal, despite a much less
pronounced 5hmC level detected in the maternal pronucleus
(Wossidlo et al., 2011; Bakhtari and Ross, 2014). Controversial
data have been reported for ovine embryos (Jafarpour et al., 2017;
Masala et al., 2017). Jafarpour et al. reported a similar active-
demethylation pattern between male and female pronucleus,
i.e. strong 5hmC signal in both male and female pronucleus,
whereasMasala et al. found 5hmC signal restricted to the paternal
pronucleus (Jafarpour et al., 2017; Masala et al., 2017). In horse
embryos produced by intracytoplasmic sperm injection (ICSI),
both paternal and maternal pronuclei display strong 5hmC
signals from PN1 to PN4, yet 5mC levels in both pronuclei are
largely unchanged throughout pronuclear development (Heras
et al., 2017). Furthermore, these studies reported species-specific
TET expression in in vitro fertilized (IVF) and in vivo embryos,
as well as aberrant demethylation in somatic cell nuclear transfer
(SCNT) embryos (Cao et al., 2014; Zhang S. et al., 2016).
The significant differences in staining between species suggest
that additional methods that reduce the potential artifacts of
immunostaining are essential to bring clarity on the conserved
features of DNA demethylation in domestic animal embryos. A
recent study used whole-genome, single-base DNA methylation
profiling of individual porcine blastocysts, generated in vivo
or by different IVF processes, and showed abnormally higher
methylation levels and lower expression of Dnmt1, Uhrf1, and
Dnmt3b in conventional IVF blastocysts compared to in vivo
produced embryos (Canovas et al., 2017). These findings warrant
further investigation into global demethylation of early embryos
of different species and embryos generated by different assisted
reproductive techniques.
Erasure-Resistant Loci and Epigenetic
Inheritance
During global DNA demethylation in preimplantation
embryos, methylation at loci with parental-specific imprints,
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retrotransposons as well as a portion of differentially methylated
CGIs in oocyte-specific and sperm-specific methylated regions
are at least partially maintained (Kobayashi et al., 2012; Smith
et al., 2012, 2014; Monk, 2015). These methylated regions
may be affected by parental life experience as well as in utero
environment, which could be potential carriers of parental and
early life epigenetic information and contribute to epigenetic
inheritance. Recent studies show that the sperm methylome can
be affected in one or multiple generations by diet (Holland et al.,
2016), obesity (Donkin et al., 2016), drug addiction (Feng et al.,
2015), stress/traumatic exposure (Franklin et al., 2010; Dias and
Ressler, 2014; Gapp et al., 2014b), and toxins in the environment
(Skinner et al., 2013; Nilsson and Skinner, 2015). Few studies
report altered epigenetic signatures through the female germline,
as it is difficult to separate them from the effects of in utero
variations, including maternal hyperglycemia and gestational
diabetes (Vrachnis et al., 2012).
Several factors have been shown to contribute to methylation
maintenance at specific loci. Dnmt1 and Dnmt1o, the oocyte-
specific form of Dnmt1, contribute to DNA methylation
maintenance at imprinted regions (Howell et al., 2001;
Ratnam et al., 2002; Hirasawa et al., 2008). Interestingly,
similar methylation-protective function of Dnmt1 has been
observed in mouse PGCs in the absence of Uhrf1, which is
suggested to regulate meiosis-related genes and ensure germline
differentiation at the appropriate time (Hargan-Calvopina et al.,
2016). Stella/PGC7 protects the maternal genome and ICRs
(Imprinting Control Regions) from active demethylation via
interaction with histone H3K9me2. In the absence of Stella,
loss of 5mC is observed in both pronuclei, accompanied by
5hmC accumulation in the maternal pronucleus (Wossidlo
et al., 2011). Trim28/Zfp57 repressive complex which recruits
Dnmt1/Uhrf1 as well as Dnmt3a/b is viewed as a non-canonical
mechanism of maintaining DNA methylation at ICRs and
retrotransposons in preimplantation embryos (Ideraabdullah
et al., 2011; Strogantsev et al., 2015). Still, as most of these factors
are found at ICRs and retrotransposons, it remains unclear
whether similar mechanisms contribute to the maintenance
of other methylated regions, especially methylation at genic
regions. The Trim28/Zfp57 complex, as well as other Krüppel
associated box (KRAB) family members with similar properties
as Zfp57, could be potential mediators (Quenneville et al., 2011;
Strogantsev et al., 2015). A recent study indicates that loss of
maternal Trim28 leads to male-predominant embryo lethality
before implantation due to demethylation and activation of
Rbmy1a1 gene, a testis-specific RNA-binding protein involved
in alternative mRNA splicing (Sampath Kumar et al., 2017),
which emphasizes the significance of methylation-protection
mechanisms during early development. Interestingly, higher
methylation level of the maternal genome compared to paternal
genome is detected at a wide variety of genomic loci in both
human embryonic and extra-embryonic lineages from 2-cell
to early postimplantation stage, suggesting a potential role of
preferential hypermethylation at maternal genome (Zhu et al.,
2018). Overall, maintenance of DNA methylation at imprinted
genes, retrotransposons and other unidentified genomic regions
during epigenetic reprogramming appears to be required for
normal development and viability. The identity and function,
as well as the maintenance mechanism(s) of these methylated
regions, are worth further exploration.
Epigenetic Reprogramming in
PGCs—Difference Between Rodent and
Non-rodent Mammals
The maintenance of methylation at imprinted regions is one of
the key differences between global demethylation in embryos and
in PGCs. Based on DNA methylation and expression profiles
obtained from mouse PGCs (mPGCs), global demethylation
in PGCs is mediated by two known mechanisms. The first
mechanism is replication-dependent demethylation caused by
repression of Dnmt3a/b and Uhrf1 expression, which leads to
gradual loss of 5mC globally in pre-gonadal PGCs. The second
mechanism, which operates mainly in mouse gonadal PGCs,
is mediated via Tet1/2 which erase methylation at specific
regions such as imprinted regions and germline-specific genes
(Seisenberger et al., 2012; Wu and Zhang, 2014). This temporal
and mechanistic separation of DNA demethylation in mPGC
is suggested to safeguard the timing of germline differentiation
(Hargan-Calvopina et al., 2016). The function of Tet1/2 on
imprint erasure has been shown in several studies (Dawlaty
et al., 2013; Hackett et al., 2013; Yamaguchi et al., 2013a,b).
Tet1 may also be involved in regulation of meiosis (Yamaguchi
et al., 2012), yet fertility of Tet1/2 single KO and double
male KO mice is overtly normal (Table 1), which questions
the functional redundancy and specificity of Tet proteins as
well as the necessity of Tet1/2 during PGC demethylation and
development. Alternatively, Tet1/2 and 5mC oxidation may be
required to “kick-start” the demethylation process (Hahn et al.,
2014).
The overall DNA demethylation dynamics are similar
between mouse and human foetal germline. The methylome
of gonadal PGCs reaches its lowest level at E13.5 in mouse
and week 10 (Wk10) in human, with most promoters and
retrotransposons demethylated, yet global gene upregulation
does not occur and genome integrity is protected, indicating
the global uncoupling of DNA methylation and transcription
during epigenetic reprogramming in PGCs. Still, in human
PGCs (hPGCs) demethylated promoters of somemeiosis-specific
genes, such as KRAB-zinc finger proteins (ZFP) and genes of
the P-element Induced Wimpy testis (PIWI) pathway, show
correlation with increased expression, and are therefore named
‘methylation-sensitive genes’. It is likely that inmammalian PGCs
active demethylation at certain regions is required for regulation
of germline-specific genes and germline differentiation (Tang
et al., 2015; Hargan-Calvopina et al., 2016).
There are key features, at both transcriptional and epigenetic
level, that differ between mouse and human PGC development.
The temporal and mechanistic separation of DNA demethylation
in mPGC may not be conserved in hPGCs. For example, the
timing of imprinting erasure is earlier in hPGCs, possibly starting
during the migratory phase (before Wk4). This observation is
further supported by the upregulation of TET1 and detection
of 5hmC in Wk4 hPGCs (Guo et al., 2015; Tang et al.,
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TABLE 1 | Key regulators for DNA modifications and their knockout effects.
Key DNA modification writer and editors Effects of mutants
Dnmt1 KO
Embryonic lethality (Liao et al., 2015)
Conditional KO in PGCs lead to precocious meiosis in female PGCs and prospermatogonia differentiation in male
PGCs (Hargan-Calvopina et al., 2016)
Upregulation of post-migratory germ cell-specific genes in the somatic cells of the postimplantation embryo
(Maatouk et al., 2006)
Dnmt3a KO Postnatal lethality (Liao et al., 2015)
Dnmt3b KO Embryonic lethality (Liao et al., 2015)
Dnmt3l KO Defects in meiosis (Vlachogiannis et al., 2015)
Tet1 KO Viable and fertile (Dawlaty et al., 2011) Defects in imprinting erasure, smaller body size and subfertility (Yamaguchi
et al., 2013b) Defects in meiosis (Yamaguchi et al., 2012)
Tet2 KO
Defects in hematopoietic cell homeostasis(Li et al., 2011)
Viable and fertile (Wang et al., 2013)
Maternal Tet3 KO Neonatal sublethality (Inoue et al., 2015; Tsukada et al., 2015)
Tet3 KO Neonatal lethality (Gu et al., 2011; Wang et al., 2013)
Tet1/2 DKO
Viable (Wang et al., 2013)
Reduction in fertility (Dawlaty et al., 2013)
Tet TKO Impaired morphogenesis and patterning. No headfolds, heart, somites and gut tube formed by E8.5 (Dai et al.,
2016)
Alkbh1 KO
Spermatogenic defects which lead to skewed sex ratio, unilateral defects in eye development and embryonic or
postnatal lethality, ranging from E9.5 to P28 (Nordstrand et al., 2010)
Defect in placental trophoblast lineage development (Pan et al., 2008)
Increased 6mA level in Alkbh1-KO mESCs (Wu et al., 2016)
Fat mass and obesity-associated protein (Fto)
Adipocyte size is smaller in Fto-KO mice when compared to WT mice after fed HFD (Church et al., 2009; Fischer
et al., 2009; Ronkainen et al., 2015)
KD and overexpression of FTO in two human cell lines (Jurkat-T, 293T) lead to increased and decreased 6mA
contents respectively (Huang et al., 2015)
Thymine DNA glycosylase (TDG) KO Embryonic lethality (Cortázar et al., 2011; Cortellino et al., 2011)
2015). In contrast, these changes are only observed in early
gonadal mPGCs (after E9.5) (Chuva de Sousa Lopes et al.,
2008; Guo et al., 2015; Tang et al., 2015; von Meyenn and
Reik, 2015). Partial erasure of 5mC coupled with increased level
of 5hmC at H19 and GNAS ICRs are also reported in day 4
(d4) and d5 human PGC-like cells (hPGCLCs) produced in
vitro, which represent pre migratory PGCs (Tang et al., 2015).
In contrast, DNA demethylation at H19 promoter region is
only detected after Wk9 in hPGCs (Eguizabal et al., 2016),
suggesting that there is significant asynchrony in imprinted gene
demethylation in human. Inaccessibility of human embryos at
earlier stages prohibits investigations of the in vivo demethylation
dynamics before week 4, i.e., during hPGC specification and early
migration. Thus, developing a model that shares developmental
mechanisms with human can be very informative for improving
human PGC in vitro differentiation systems and for better
understanding human PGC development. Our laboratory has
developed the pig model, which closely resembles human
development during the first three weeks of life. We showed that
PGC develop in a similar fashion to what is known in human, and
contrasts the process described in mice (Kobayashi et al., 2017).
We showed that global reduction of 5mC and H3K9me2,
as well as repression of the epigenetic modifiers UHRF1 and
EHMT2/G9a, in newly specified (E14) pre- and early migratory
(E16) pig PGCs (Kobayashi et al., 2017). This finding indicates
an earlier initiation of epigenetic reprogramming compared
to mouse PGCs, but consistent with the timing in hPGCLCs
(Kobayashi et al., 2017). Interestingly, along with the reduction
of 5mC, TET1 and 5hmC levels are significantly enriched in
pre- and early migratory pig PGCs, consistent with largely
erased imprinting in Wk4 hPGCs and expression changes of
DNMT3a/b, UHRF1, and TET2 in early hPGCLCs (Kobayashi
et al., 2017). In agreement with these findings, we showed that
demethylation of the imprinted IGF2R in male pig PGCs initiates
before pig PGCs reach the gonads (Hyldig et al., 2011).
Furthermore, nascent PGC cease to proliferate, suggesting
that DNA demethylation is an active process dependent on
recruitment of specific factors, such as Tet enzymes in pig PGCs
(Kobayashi et al., 2017). These findings show a temporal and
mechanistic difference of epigenetic reprogramming between
rodents and non-rodent PGCs (Kobayashi et al., 2017).
Consistent with these observations in the pig, 5mC and
H3K9me2 is also significantly lower in Cynomolgus monkey
PGCs from as early as ∼E17 and E20, respectively (Sasaki et al.,
2016), further indicating a difference between PGC development
in rodents and non-rodent mammals. Given the similarities
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between human and porcine embryos at a morphological,
transcriptional and epigenetic level, as well as the accessibility
of porcine embryos, the pig is a suitable surrogate model for
investigating epigenetic reprogramming in human early PGCs
and early embryos when combined with in vitro models for
human embryonic development.
Although the methylated regions maintained during the
reprogramming wave in preimplantation embryos are potential
carriers of parental ‘epimutations’, they also need to ‘escape’
the global demethylation in PGCs to be able to contribute
to transgenerational epigenetic inheritance. The idea of
transgenerational inheritance of epigenetic states in mammal
was first proposed about 30 years ago (Holliday, 1987; Laird,
1987). Although there is no definitive proof to show that DNA
methylation marks can be maintained in germline and inherited
across multiple generations in mammals, recent evidence
suggests that DNA methylation at some genomic loci can escape
both waves of epigenetic reprogramming (Seisenberger et al.,
2012; Hackett et al., 2013; Guo et al., 2015; Tang et al., 2015).
These regions are termed ‘escapees’, and a group of these escapees
are repeat-poor, single copy genes which are associated with
metabolic and neurological disorders (Tang et al., 2015).
Overall, redundant mechanisms have evolved to act in
parallel for the efficient erasure of epigenetic marks in early
embryos and PGCs, yet several mechanisms also exist to
protect methylation at specific genomic regions, which could
contribute to epigenetic inheritance. These demethylation and
methylation-protection mechanisms may differ between rodent
and non-rodent mammals given the different demethylation
dynamics reported, suggesting recent and presumably ongoing
evolutionary selection processes.
SPECIFIC FEATURES OF 5hmC
5hmC as a Regulatory Marker
5hmC is mainly viewed as an intermediate product of active
demethylation and is rapidly removed during replication
(Inoue and Zhang, 2011) or further oxidized to 5fC and
5caC. However, the non-reciprocal pattern between 5mC and
5hmC and the dynamics of hydroxymethylation observed
during late oogenesis and early embryo development in
multiple mammalian species suggest an additional biological
role for 5hmC in early development (Masala et al., 2017).
The enrichment of 5hmC and TET1/2 before and during
pig PGC specification and early hPGCLC development also
indicates the necessity of hydroxymethylation in non-rodent
PGC development. The stability and abundance of 5hmC
observed in mESCs further supports its biological significance
(Bachman et al., 2014; Zhao et al., 2014). Still, the contribution
of Tet proteins and 5hmC to pluripotency and differentiation
is controversial. In mouse preimplantation embryos and mESC
Tet functions are linked with pluripotency genes. For example,
Tet3 deficiency in oocytes hinders DNA demethylation of the
paternal Oct4 and Nanog genes in early embryos, and leads
to delayed activation of a paternally derived Oct4 transgene
(Gu et al., 2011; Guo F. et al., 2014). During somatic cell
reprogramming of mouse induced-pluripotent cells (iPSCs),
Tet1 and Tet2 interact with Nanog and redundantly enhance
Nanog-mediated reprogramming to pluripotency. However,
recent data indicate that Tet1 and Tet2 have opposing effects
during the establishment of naïve pluripotency, which is the
‘ground’ state of pluripotency in naïve epiblast in mice (Fidalgo
et al., 2016). Tet1 partners with Zfp281 for establishing and
maintaining primed pluripotency, and thereby also negatively
regulates Tet2 expression. Ectopic expression of Tet2 alone in
mESCs, but not Tet1 or Tet3, promotes reprogramming to
naïve pluripotency, whereas knockdown (KD) of Tet2 leads to
significantly reduced 5hmC at naïve pluripotency genes and
compromised reprogramming to naïve state (Fidalgo et al., 2016).
Other pluripotency genes, such as Oct4 (Piccolo et al., 2013)
and Lin28 (Jiang and Baltimore, 2016; Tan and Yeo, 2016; Zeng
et al., 2016), have also been related with Tet recruitment and its
enzymatic activity.
It is largely unclear in which regions Tet-mediated active
demethylation and 5hmC have transcriptional-regulating roles
during pre-implantation embryo and PGC development. A
recent study suggests that the enzymatic activity of Tet
proteins, specifically of Tet3, is required for antagonizing
Dnmt3a/b functions and regulating Lefty–Nodal signaling
during gastrulation (Dai et al., 2016). Still, it remains unclear
whether the requirement of Tet-mediated active demethylation is
due to (1) protection of Lefty regions from passive demethylation
and/or (2) a specific role of 5hmC at these loci. The
transcriptional regulatory function of 5hmC may depend on
different binding properties compared to 5mC or unmethylated
C, leading to a specific protein-binding profile at 5hmC-enriched
regions. For example, binding of MeCP2, Mbd3, and Uhrf1 to
5hmC was detected in vitro and in genomic DNA of mESCs
and in the nervous system (Frauer et al., 2011; Yildirim et al.,
2011; Mellén et al., 2012; Iurlaro et al., 2013; Chen et al., 2014).
However, further studies suggest no binding preference for 5hmC
and therefore these three proteins are unlikely to be 5hmC-
specific readers (Hashimoto et al., 2012; Mellén et al., 2012;
Baubec et al., 2013; Spruijt et al., 2013; Cui and Irudayaraj, 2015;
Gabel et al., 2015; Hainer et al., 2016). Additional uncharacterized
proteins have been identified as 5hmC readers by Spruijt et al.
(2013). For example, Uhrf2, a close relative of Uhrf1, shows
strong preference for 5hmC and is considered a bona fide 5hmC
reader (Spruijt et al., 2013). A further study reveals the structural
basis of Uhrf2’s preference for 5hmC (Zhou et al., 2014). KO
of Uhrf2 in mice leads to reduction of 5hmC in the cortex and
the hippocampus, along with abnormal expression of neuronal-
related genes and defects in spatial learning and memory (Chen
R. et al., 2017). Another 5hmC-interacting protein identified
is C3ORF37/Hmces/Srap1, a eukaryotic member of the SRAP
superfamily (Aravind et al., 2013) that functions as an eraser
of 5hmC, in vitro and in mESCs. Srap1 KO causes sub-
lethality in pre-implantation blastocysts, but the mutant mice
are fertile, suggesting an unaffected PGC development (Kweon
et al., 2017) and different reprogramming mechanisms between
preimplantation embryo and PGCs.
Current genome-wide 5hmC detection techniques are not
ideal for studies in early embryos or PGCs due to the amount
of starting material required (Yu et al., 2012; Petterson et al.,
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2014; Wu et al., 2014), as well as other technical limitations
such as low genomic coverage (Sun et al., 2013; Han et al.,
2016). Still, extensive research in mESCs and several other cell
lines has shed some light on potential roles of 5hmC (Wu and
Zhang, 2011; Xu et al., 2011; Cimmino and Aifantis, 2017). The
correlation between 5hmC and gene expression appears to be
quite diverse and spatiotemporal-dependent. The genomic 5hmC
pattern itself is also highly dynamic, which has been correlated
with lineage-commitment gene expression and tissue-specific
biological processes (Nestor et al., 2012; Lin et al., 2017; Ponnaluri
et al., 2017). In general, 5hmC enrichment on gene bodies is
linked with gene activation (Wu and Zhang, 2011; Guo et al.,
2016; Lin et al., 2017; Ponnaluri et al., 2017). However, the effect
of 5hmC enrichment on gene bodies has also been described
as ‘mildly inhibitory’, as it correlates with modest gene up-
regulation (Neri et al., 2013). 5hmC on promoters and enhancers
correlates with both active (Ficz et al., 2011; Stroud et al., 2011;
Deplus et al., 2013) and repressed genes (Williams et al., 2011;
Wu and Zhang, 2011; Choi et al., 2014; Kim et al., 2014; Zhang
X. et al., 2016). Genomic 5hmC distribution is largely dependent
on the activities of Tet proteins, which preferentially bind to
promoters and gene bodies, but also enhancers with affinity that
correlates with CpG density (Stroud et al., 2011; Williams et al.,
2011; Branco et al., 2012). Tet1 and Tet3 contain a DNA binding
CxxC domain which Tet2 lacks, yet the functional redundancy
and specificity of Tets are still unresolved. Apart from potentially
different contributions to pluripotency, in mouse embryo, Tet1,
2, and 3 also show distinct expression profiles, suggesting that
the requirement of Tet activities are highly context-dependent
(Khoueiry et al., 2017). Also, Tet1, and Tet2 show different
localization in the genome, albeit with some overlap. Tet1 is
suggested to be mainly responsible for 5hmC generation at
promoters and some enhancers, while Tet2 with 5hmC is present
along gene bodies (Huang et al., 2014). Reduced 5hmC and
increased 5mC are observed at enhancers in Tet2−/− mESCs,
which leads to reduced activities in a subset of enhancers and
gene activation during mESC differentiation to neuronal fate,
suggesting that Tet1 plays a role in the oxidation of some
enhancers (Hon et al., 2014). The role of Tet proteins, especially
around transcription start sites (TSSs), could be independent of
their catalytic function (Williams et al., 2011), and more related
to their interaction/recruitment with other proteins such as O-
Linked N-Acetylglucosamine (GlcNAc) Transferase (OGT) and
Polycomb repressive complex 2 (PRC2) at CpG-rich regions (Wu
et al., 2011; Xu et al., 2011; Chen et al., 2013; Deplus et al., 2013;
Neri et al., 2013; Vella et al., 2013). This may in part explain the
active and repressive roles of 5hmC. It is also possible that the
genomic context of 5hmC contribute to the regulation of specific
genes during development and differentiation by modulating
chromatin accessibility (Ruzov et al., 2011). In foetal germ cells,
genes with intermediate 5hmC levels of promoter regions are
more likely to display higher chromatin accessibility and also
have higher gene expression (Guo et al., 2016). Tet activity
on insulators may also regulate gene expression by altering
chromosomal architecture (Marina et al., 2016). 5hmC and
Tet activities may affect other epigenetic markers or modifiers.
For example, the correlation between 5hmC and bivalency, a
poised epigenetic state defined by co-existence of active marker
H3Lys4-trimethylation (H3K4me3) and repressive H3Lys27-
trimethylation (H3K27me3), characteristic of pluripotent cells,
has been reported in multiple studies (Pastor et al., 2011; Gao
et al., 2013; Neri et al., 2013; Kong et al., 2016).
The 5mC/5hmC Asymmetry
5mC on DNA strands is considered symmetrical and is
maintained by Dnmt1/Uhrf1 through replication, whereas Tet-
mediated active demethylation from 5mC is the only known
origin of 5hmC, with no known mechanism for maintenance
through cell proliferation. Interestingly, asymmetric distribution
and inheritance of 5hmC on complementary CpG sites between
Watson andCrick strands (CpG dyads) is observed duringmouse
early embryogenesis (Guo H. et al., 2014; Mooijman et al., 2016)
and in adult stem cells (Huh et al., 2013). This asymmetry is
suggested to bemostly 5mC/5hmC, but unlikely to be C/5hmC or
C/5mC at single CpG sites (Zhao et al., 2014). A high 5mC/5hmC
abundance at CpG dyads was also found in mESCs using a novel
detection technique, suggesting potential biological functions for
the 5mC/5hmC modification status (Song et al., 2016). In vitro
assays indicate that Uhrf1 and Dnmt3A can recognize hemi-
hydroxymethylated substrates, whereas Dnmt1 cannot (Frauer
et al., 2011). Further investigation of the activities of Tet proteins
and Dnmt proteins in vivo may reveal if the 5mC/5hmC
asymmetry could be established by preferential oxidization,
maintenance or de novo establishment of methylation on only
one strand of 5mC/5mCpGs.
5fC AND 5caC: INTERMEDIATES OF
DEMETHYLATION OR REGULATORY
MARKERS?
5fC and 5caC were considered as transient intermediate products
of Tet-mediated active demethylation. During this process these
modifications are removed by either passive dilution during
replication, or are excised by thymine DNA glycosylase (Tdg)
followed with base excision repair (BER) for replacement of an
unmodified cytosine (He X.-J. et al., 2011; Maiti and Drohat,
2011). A recent study suggests that C3ORF37/Hmces/Srap1
functions as an eraser for 5fC and 5caC in mESCs (Kweon
et al., 2017). The presence of 5fC (0.06–0.6% of 5mC) and 5caC
(0.01% of 5mC) in the mammalian genome is extremely low
compared to 5hmC and 5mC (Ito et al., 2011; Pfaffeneder et al.,
2011; Booth et al., 2014; Bachman et al., 2015). One potential
explanation for this low occurrence is the preference of Tet
for 5mC over 5hmC/5fC (Hu et al., 2015). Administration of
stable isotope [methyl-13CD3]L-methionine tracked with liquid
chromatography coupled to mass spectrometry/high resolution
mass spectrometry (LC-MS/HRMS) further indicates that 5fC
is a stable DNA modification in mESCs (Bachman et al., 2015).
The stability of 5fC is also supported by another study indicating
that the majority of 5fC at CpG sites is not removed via passive
dilution during the gamete to 4-cell stage progression of the
mouse embryo (Guo H. et al., 2014). However, neither 5fC nor
5caC were detected by mass spectrometry 8 h post-fertilization
(Okamoto et al., 2016). Although 5fC and 5caC are considered
relatively stable during mouse PGC development (E9.5 to E12.5),
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both epigenetic marks are not detected in human PGCs at
comparable stages (Wk4-9) (Yamaguchi et al., 2013a; Tang et al.,
2015).
Distribution of 5fC and 5caC
Reports indicate that 5fC and 5caC may stably exist at specific
genomic regions, with distinct effects on gene expression. Several
studies reported that 5fC/5caC overlap with H3K4me1 marked
regions which are associated with active or poised transcription
(Shen et al., 2013; Song et al., 2013; Wu et al., 2014). In Tdg
KO mESCs, promoters with silent or bivalent histone marks,
as well as active enhancers and pluripotency TF-binding sites
are enriched for ectopic 5fC/5caC signals, indicating potential
roles of 5fC/5caC and targeted demethylation mediated via Tdg
in mESCs (Shen et al., 2013). As ectopic 5fC/5caC are also
enriched at promoters of genes with low-to-medium expression
levels, they are considered as ‘mildly repressive’ (Shen et al.,
2013). Poised enhancers show enriched 5fC in mESCs, and p300-
based activation of enhancers coincides with an increase of 5fC
in Tdg-KO mESCs (Song et al., 2013). Single-base mapping
of 5fC and 5caC further confirm their enrichment at active
enhancers and reveal differential genomic profiles for 5fC and
5caC, with 5fC more frequently present in exons and promoter
regions, and 5caC more frequently present in intronic regions.
5fC and 5caC are also detected with different sequence preference
and binding sites of pluripotent genes. The gradient of 5mC,
5hmC, 5fC, and 5caC further indicates the correlation between
Tet-mediate demethylation and the activation of regulatory
elements in mESCs (Lu et al., 2015). Apart from the enrichment
of 5fC on active enhancer regions, single-based 5fC profiles
in multiple tissues also indicates clear tissue specificity of
5fC distribution (Iurlaro et al., 2016). More recently, 5fC
was profiled in mouse early embryos in single cells at single
base resolution, revealing stage-specific and parental-specific
dynamics of 5fC. Interestingly, a critical set of developmental
and metabolic related genes shows 5fC enrichment on promoters
before gene upregulation (Zhu et al., 2017), which is also
supported by the finding of transient 5caC accumulation at
promoter regions preceding gene expression during lineage
specification and differentiation (Lewis et al., 2017). These results
highlight a fine balance between Tet oxidation and Tdg excision,
suggesting potential roles for 5fC/5caC and Tet/Tdg-mediated
demethylation in embryonic development as well as tissue-
specific processes. However, removal of 5fC/5caC is largely
independent of Tdg in both pre-implantation embryos (Guo
F. et al., 2014; Guo H. et al., 2014; Zhu et al., 2017) and
in mammalian PGCs (Yamaguchi et al., 2013a; Tang et al.,
2015). This raises questions about the stability of 5fC/5caC over
replication-dependent passive dilution and suggests the existence
of other removal mechanisms, such as the recently identified Srap
nuclease (Kweon et al., 2017).
Specific Functions and Protein Binding
Partners for 5fC and 5caC
Several studies have focused on the potential mechanisms
underlying the correlations between 5fC/5caC and the biological
processes mentioned above (Spruijt et al., 2013; Song and Pfeifer,
2016). In vitro assays indicate that 5fC and 5caC lead to altered
transcriptional properties, including increased backtracking,
increased pausing, and reduced fidelity of mammalian RNA
polymerase II (Pol II) in nucleotide incorporation (Kellinger
et al., 2012). Structural and biochemical analysis show that
specific hydrogen bonds are formed between the 5-carboxyl
group of 5caC and the conserved epi-DNA recognition loop
in Pol II. Comparison between Tdg-KO and wild-type mESCs
shows a clear reduction of Pol II elongation in Tdg-KO cells,
suggesting that 5fC/5caC at gene bodies function as another
layer of fine-tuning of Pol II transcription elongation in vivo
(Wang et al., 2015). 5fC was reported to alter the DNA double
helix structure which is likely to lead to helical unwinding in
vitro (Raiber et al., 2015). However, compared to equivalent
unmodified duplexes and sequence variants 5fC does not
significantly affect the structure of the DNA double helix in a
crystalline state (Hardwick et al., 2017). The alteration described
by Raiber et al. (2015) is not unique to 5fC modified sequences,
and therefore is unlikely to be the basis for 5fC recognition
(Hardwick et al., 2017). Still, 5fC may trigger biological events
by affecting the mechanical properties of DNA, for example,
by increasing DNA flexibility (Ngo et al., 2016). Ngo et al.
also show that 5hmC enhances flexibility, but is less effective
compared to 5fC, while 5mC reduces flexibility and 5caC is
similar to unmodified cytosine in terms of structural qualities.
DNA flexibility positively affects nucleosome stability, whichmay
link 5fC with its regulatory role of gene expression at enhancer
regions (Ngo et al., 2015, 2016). Protein binding affinity, which
includes binding to histone octamers, is also affected by DNA
flexibility (Peters and Maher, 2010). Screens for binding proteins
indicates that there are more proteins with a strong preference
for 5fC compared to 5hmC, revealing the existence of potential
‘readers’ for 5fCwhich are involved in several biological processes
including transcription regulation, chromatin regulation and
DNA repair (Iurlaro et al., 2013).
Overall, although the stability of 5fC and 5caC requires
validation, current data suggests that potential functions of 5fC
and 5caC as well as their modifiers and readers are worth
further investigations, especially in early embryos and PGCs
with ongoing global DNA demethylation. Newly developed
techniques which are cost-effective (Neri et al., 2016) and require
small numbers of cells (Zhu et al., 2017) will be helpful in
future studies to resolve these issues. Different biochemical
characteristic of 5hmC/5fC/5caC and their biological roles, if
validated, represent additional regulatory layers during active
removal of 5mC.
6mA
6mA, the most prevalent DNA modification in prokaryotes is
used by bacteria to regulate the gene expression program related
to DNA repair (Messer and Noyer-Weidner, 1988), virulence
(Sarnacki et al., 2013) and cellular defense (Zaleski et al., 2005).
Interestingly, 6mA is considered a novel epigenetic mark in
eukaryotes, as it has been reported only recently in several fungi
(Mondo et al., 2017), ciliates (Tetrahymena thermophila) (Wang
Y. et al., 2017), green algae (Chlamydomonas Reinhardtii) (Fu
et al., 2015), nematodes (Caenorhabditis elegans) (Greer et al.,
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 March 2018 | Volume 6 | Article 24
Zhu et al. Novel DNA Modifications
2015), fruit fly (Drosophila melanogaster) (Luo et al., 2015;
Zhang et al., 2015; O’Brown and Greer, 2016), zebrafish (Danio
rerio) (Liu J. et al., 2016), african clawed frog (Xenopus laevis)
(Koziol et al., 2016), and mammals (Koziol et al., 2016; Liu J.
et al., 2016). Potential biological functions of 6mA in eukaryotes
include regulation of gene transcription (Fu et al., 2015; Wu
et al., 2016; Mondo et al., 2017), cell cycle, transposon activities
(Zhang et al., 2015; Liu J. et al., 2016), nucleosome positioning
(Mondo et al., 2017), as well as ribosomal DNA preservation
(Blackburn et al., 1983; Wang Y. et al., 2017) and crosstalk
with histone modification (H3K4me2), which contributes to
transgenerational epigenetic inheritance (Greer et al., 2015). An
in vitro study further reported a specific pausing effect of 6mA
on yeast RNA polymerase II (pol II) (Wang W. et al., 2017).
However, the epigenome of C. elegans and D. melanogaster could
be largely different to that of mammals, as they are nearly
devoid of 5mC (Capuano et al., 2014; Greer et al., 2015; Zhang
et al., 2015). Therefore, a potentially highly divergent distribution
and functions of 6mA occurring in these organisms may not
be conserved in vertebrates. Indeed, 6mA level in vertebrates
is extremely low in various examined tissues, from 0.00009%
6mA/A detected in X. laevis tissues (Koziol et al., 2016) to the
highest of ∼0.1–0.2% 6mA/A during early embryogenesis of
zebrafish and pig (Liu J. et al., 2016). Also, the distribution of
6mA seems highly species-specific. In X. laevis tissues and mouse
tissues, the peaks of 6mA are mainly found in non-genic regions,
while only a small set of genes contains 6mA (Koziol et al.,
2016). 6mA at genic regions is more frequent at introns and is
nearly depleted from TSSs and exons, which is in contrast to
the enrichment of 6mA at or following TSS in Chlamydomonas
and Drosophila genomes, or the even distribution of 6mA in C.
elegans genome. 6mA is also enriched at intergenic over promoter
regions in zebrafish oocytes and early embryos. However, in
contrast to the above result in X. laevis and mouse tissue, 6mA
DNA immunoprecipitation sequencing (DIP-seq) revealed slight
6mA enrichment after TSSs and at exons instead of introns
in zebrafish (Liu J. et al., 2016). Most interestingly, in several
eukaryotic species, a large portion of 6mA detection peaks are
within repetitive elements (REs), especially in simple repeat
regions. Based on these findings, significant motif sequences have
been identified in simple repeats and other REs (Liu J. et al., 2016;
Wu et al., 2016).
Other distinct features of 6mA have also been revealed,
indicating that despite the overall low level of 6mA, this particular
DNA modification could be very dynamic and functionally
important in vertebrates. Half of the 6mA sites in X. laevis
tissues and mouse kidney seem to be tissue-specific, and GO
term analysis indicates that genes modified by 6mA are linked to
different pathways, which could indicate either a tissue-specific
role, or a species-specific role of 6mA modification (Koziol
et al., 2016). Abundance of 6mA in oocytes and early embryo
of zebrafish and pig (0.1–0.2% 6mA/A) (Liu J. et al., 2016)
suggests a specific role of 6mA in early embryo development of
6mA. Interestingly, cancer cells and tissues display significantly
decreased 6mA levels when compared to normal cells and
tissues, whereas cultured cells show hundred-fold elevated 6mA
levels compared to in vivo tissues, in both human and mouse
(Liang et al., 2016). These results suggest that 6mA abundance
could rapidly alter during changes of cell identity. KO of
Alkbh1 in mESC, a possible 6mA demethylase, revealed 550
downregulated genes which are enriched in development and
lineage specification factors. In addition, imbalanced cell fate
decisions during differentiation further suggest a critical role of
6mA in early development. In Alkbh1 KO mESCs, 6mA was
found significantly enriched at the retained 5′ UTR and open
reading frame 1 (ORF1) regions of full-length, evolutionarily
young long interspersed nuclear element 1 (L1/LINE-1), along
with elevated 5mC levels compared to wild-type mESCs. Further
analysis indicated that active transposable elements–of the LINE-
1 class - could be repressed by 6mA, and thereby function as a
silencing center for neighboring genes during differentiation (Wu
et al., 2016), which contradicts previous suggestions that 6mA
may be an active mark for gene expression in lower eukaryotes
(Fu et al., 2015; Mondo et al., 2017). Extra deposition of 6mA on
the X chromosome in Alkbh1 KOmESCs is also reported to have
a long-lasting, repressive effect, which may partially explain the
imbalanced cell fate decision observed during Alkbh1 KOmESCs
differentiation. However, the observation of Alkbh1 as a 6mA
demethylase was not supported by another study using Alkbh1
knockout mESCs and mouse embryonic fibroblasts (MEFs) as
well as in vitro biochemical assays (Liu F. et al., 2016). Instead,
Liu et al. suggest that Alkbh1 is a demethylase of m1A (N1-
methyladenosine on RNA), which affects the initiator methionyl-
transfer RNA (tRNAiMet) level and translation initiation in
mammalian cell lines. Moreover, the existence of 6mA in mESCs
and mouse tissues was recently questioned by a highly sensitive
LC-MS method; in parallel, the same approach successfully
detected 6mA at a level of 0.7% 6mA/A in Chlamydomonas
Reinhardtii genome (Schiffers et al., 2017). The authors suggested
that the previous sequencing-derived data of 6mA in mESCs
might be caused by degraded bacterial DNA which provides
the 6mA nucleoside incorporated into mESC DNA (Schiffers
et al., 2017). Therefore, further profiling and validation of DNA
and RNA modification in wild type and Alkbh1 KO mammalian
cell lines with different detection methods and contamination-
eliminating strategies may help solve the controversy. In human
cell lines, Fat mass and obesity-associated protein (FTO),
which has previously been identified as a demethylase for N6-
methadenine on RNAs (m6A) both in vivo (Shen et al., 2015) and
in vitro (Jia et al., 2011), is suggested as another 6mA demethylase
(Huang et al., 2015). Interestingly, the level of N6-methadenine
on both DNA and RNA (Klungland and Dahl, 2014) seems to
correlate with cellular fat mass and may be linked to obesity and
type 2 diabetes (Huang et al., 2015).
Overall, the presence of 6mA in eukaryotic genomes,
especially lower eukaryotes, is evident, with divergent genomic
distribution and functions observed in different eukaryotic
species. Thus, it is worth further exploring novel modifications
such as 6mA. If 6mA truly has significant biological functions,
the specificity of 6mA establishment, removal and readout will
be crucial for understanding its roles. Current data indicate a
lack, or insufficient, consensus motifs for 6mA establishment
in vertebrate genomes based on in silico analysis (Koziol et al.,
2016). It is possible that the ‘modifiers’ do not recognize specific
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sequences, but are recruited by different 6mA-binding proteins.
Also, interesting features of 6mA observed in lower eukaryotes,
such as co-regulation with active histone mark H3K4me2 and
involvement in transgenerational inheritance (Greer et al., 2015),
have not been investigated in vertebrates.
It has been suggested that, in general, the levels of 6mA and
5mC have an inverse relationship in organisms throughout the
tree of life (O’Brown and Greer, 2016; Mondo et al., 2017).
There seems to be an evolutionary shift from 6mA to 5mC as
the major epigenetic mark. It is worth mentioning that the Tet
homolog is identified as 6mA demethylase in Drosophila (Zhang
et al., 2015), which supports such an evolutionary shift and
also suggests the possibility of an inverse correlation between
5mC and 6mA in eukaryotes (Breiling and Lyko, 2015). 6mA,
unlike 5mC, does not tend towards spontaneous mutations and
therefore could be advantageous for genomic stability compared
to 5mC. Interestingly, the timing of 6mA enrichment after
fertilization (Liu J. et al., 2016) overlaps with the timing of global
demethylation in zebrafish (Potok et al., 2013) and pig (Cao
et al., 2014), in spite of the overall different dynamics between
zebrafish and mammalian epigenetic reprogramming (O’Neill,
2013; Luo and He, 2017). It would be interesting to investigate
if the enrichment of 6mA is truly correlated with genome-wide
demethylation and plays repressive roles complementary to 5mC
on regions such as REs in preimplantation embryos and PGCs
(Liu F. et al., 2016; Luo and He, 2017). Whether spatiotemporal
changes of 6mA levels occur under abnormal circumstances,
such as the state of obesity and type 2 diabetes, is also worth
exploring. However, the existence of 6mA in animals andwhether
6mA is abundant or stable enough to elicit biological changes in
vertebrate genomes still remains questionable.
5mC AT NON-CpG SITES
Although DNA methylation (5mC) is predominantly found on
CpG sites in mammalian genomes, non-random distribution
of non-CpG methylation is present in the mouse and human
genome and has been studied for their biological relevance
for over a decade (Pinney, 2014; He and Ecker, 2015). Non-
CpG methylation is present in most tissues (Schultz et al.,
2015), but only prevalent in a few cell types and tissues such
as ESCs (Ramsahoye et al., 2000; Lister et al., 2009; Ziller
et al., 2011), brain (Guo J. U. et al., 2014; Kinde et al.,
2015), and oocytes (Tomizawa et al., 2011; Shirane et al.,
2013). Non-CpG methylation is also accumulated in mitotically
arrested prospermatogonia (Kobayashi et al., 2013), but is largely
lost after the resumption of mitosis (Ichiyanagi et al., 2013),
which is consistent with the lack of maintenance mechanism
for non-CpG methylation. Non-CpG methylation is almost
exclusively established by Dnmt3a/b and requires the presence
of Dnmt3L (Arand et al., 2012; Vlachogiannis et al., 2015). As
Dnmt1 generally does not contribute to non-CpG methylation,
the distribution is asymmetrical between the two strands of
individual DNA molecules. 5hmC on non-CpG sites is very rare,
even in brain (Lister et al., 2013) and ESCs (Yu et al., 2012),
suggesting that Tet-mediated demethylation is not required for
removal of non-CpG methylation.
Non-CpG methylation has been suggested to be a by-product
of Dnmt activity due to its strong link to neighboring CpG
methylation (Ziller et al., 2011; Arand et al., 2012). However,
motif analysis suggests that non-CpG methylation does have
tissue-specific site preferences in the genome (Lister et al., 2009,
2013; Vlachogiannis et al., 2015). Apart from tissue-specific
distribution, non-CpG methylation on promoters, enhancers
and gene bodies also have been associated with transcriptional
repression (Guo J. U. et al., 2014; Zhang et al., 2017) and
protein binding activities (Barrès et al., 2009; Guo J. U. et al.,
2014; Sperlazza et al., 2017). Aberrant non-CpG methylation
patterns were shown in pluripotent cells (Lister et al., 2011; Ma
et al., 2014), yet the correlation between non-CpG methylation
and pluripotent states is largely unknown (Patil et al., 2014).
Also, the prevalence of non-CpG methylation in oocytes is
worth exploring, as maternally-derived methylation could have
functions during early embryo development and therefore have
the potential as carrier of epigenetic information (Branco et al.,
2016).
5hmU
Apart from modifications on cytosine and adenine, oxidized
thymine (T) nucleobases such as 5-hydroxymethyluracil (5hmU)
are also found in mammalian cells. 5hmU was considered as a
product of oxidative lesions (Bjelland et al., 1995) and mainly
precursors of Base J (β-D-Glucopyranosyloxymethyluracil) in
eukaryotic kinetoplastid flagellates (van Luenen et al., 2012;
Reynolds et al., 2014; Kawasaki et al., 2017). A recent study
reports the presence of 5hmU in human, rat and porcine tissues
at relatively stable levels (Gackowski et al., 2015). In mESCs,
the majority of 5hmU is generated by Tet-catalyzed oxidation
of thymine instead of reactive oxygen species (ROS)-induced
oxidation. Compared to adult somatic tissue, 5hmU levels are
elevated in mESCs and are found in amounts that are comparable
to 5caC. 5hmU levels peak between 8 and 16 hours after
naïve mESCs begin differentiation towards post-implantation
epiblast, suggesting 5hmU may be largely generated during
epigenetic reprogramming (Pfaffeneder et al., 2014; Robertson
et al., 2014). Although previous studies suggest that 5hmU can
be produced via deamination of 5hmC by the Aid (activation-
induced cytidine deaminase) / Apobec (apolipoprotein BmRNA-
editing catalytic polypeptides) family of enzymes (Cortellino
et al., 2011; Guo et al., 2011), isotope tracing experiments in
mESCs suggests that 5hmC is not a 5hmU precursor (Pfaffeneder
et al., 2014). In vitro studies also suggest that 5hmC is an
unlikely substrate for enzymes of the Aid/Apobec family (Nabel
et al., 2012; Rangam et al., 2012; Budzko et al., 2017). A set
of transcription factors and chromatin remodeling factors in
nuclear extracts from mESCs have been identified as specific
readers of 5hmU sites (Pfaffeneder et al., 2014). The Tet-
mediated elevated levels of 5hmU during mESC differentiation
and the specific readers identified suggests that 5hmU may not
simply be an oxidative lesion but have regulatory roles during
early embryonic development. Further investigations of the
5hmU dynamics in mammalian model organisms are warranted
(Olinski et al., 2016).
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NOVEL MODIFICATION AND DISEASE
As DNA methylation (5mC) is a well-recognized epigenetic
regulator for gene expression, abnormality of 5mC profiles in
various diseases (Robertson, 2005), including cancer (Esteller,
2008), aging-related disease (Gassen et al., 2017), cardiovascular
diseases (Chistiakov et al., 2017), metabolic disorders (Wahl
et al., 2017), reproductive disorders (Ho et al., 2017), and
mental/neurological disorders (Nestler et al., 2016), have also
been extensively studied and documented.Many of those diseases
and their abnormal 5mC profiles may be attributable to early
life experiences, suggesting the involvement of DNAmethylation
in the Developmental Origins of Health and Disease (DOHaD)
paradigm (Leenen et al., 2016). Recent studies have also revealed
potential roles of 5hmC in disease. Reduced 5hmC levels have
been reported in a variety of cancers (Yang et al., 2013; Ficz
and Gribben, 2014; Pfeifer et al., 2014; Rasmussen and Helin,
2016), which makes loss of 5hmC a potential hallmark of cancer
(Chen Z. et al., 2017). Still, the biological consequence of the
universal loss of 5hmC in tumorigenesis is not clear. Aberrant
5hmC pattern has also be observed in aging-related diseases
(López et al., 2017), and age-related enrichment of 5hmC at
specific loci has been observed in neural system (Szulwach
et al., 2011; Chen et al., 2012). 5hmC has also been linked
with neurological/mental disorders such as depression (Tseng
et al., 2014; Gross et al., 2017), autism (Papale et al., 2015;
Madrid et al., 2016), and Parkinson’s disease (Stöger et al.,
2017), as well as developmental disorders such as fragile X
syndrome (Brasa et al., 2016; Esanov et al., 2016). On the
other hand, disease-related profiles of more recently discovered
DNA modifications remain largely unknown. For example,
decreased 6mA level has been observed in cancers (Liang et al.,
2016) and type 2 diabetes (Huang et al., 2015), suggesting
that investigation of the role of 6mA in those diseases is
needed.
FUTURE INVESTIGATION AND
CHALLENGES
All DNA modifications currently studied in mammalian
genomes display their most dynamic profiles during
epigenetic reprogramming in early development. Therefore,
preimplantation embryos and PGCs, as well as their
corresponding in vitro cell lines where epigenetic reprogramming
also occurs, provide tractable systems for studying novel DNA
modifications. Here we list a few aspects of novel DNA
modifications that are worth exploring further:
Genome-Wide Distribution of Novel
Modification During Early Development
and its Potential of Epigenetic Inheritance
Genomic distribution of novel modifications may show specific
spatiotemporal patterns during early development. Combined
with other omics data, having a clear understanding of how these
patterns are regulatedmay further our knowledge of the potential
roles of these marks in development and inheritance.
Considering the low abundance of some of the DNA
modifications, cross-validation by multiple strategies is required;
this currently limits studies in rare cell types and tissues.
For example, bisulfite sequencing is unable to distinguish
between 5mC and 5hmC, or unmethylated cytosines from
5fC and 5caC, which may lead to misinterpretation of 5mC
profiles and dynamics of active demethylation. Advanced
techniques with improved sensitivity and specificity would
allow genome-wide profiling of rare epigenetic markers in small
numbers of specific cells, including PGCs, preimplantation
embryos and sub-populations of cancer cells in vivo. This
will bring new understanding about the biological role of
those novel modifications. Also, comparing genome-wide
distribution in different stages of the lifecycle will enable the
distinction between genomic regions that maintain stable marks
from those that are susceptible to environmental influences.
Such high-resolution profiling of modifications will enhance
our understanding of the potential role of different DNA
modifications in epigenetic inheritance (Figure 1). Third-
generation sequencing, such as single-molecule real-time
(SMRT) sequencing and Nanopore sequencing, is promising
for DNA modification profiling, although the high error
rate and poor quantification accuracy of third-generation
sequencing need to be improved (Plongthongkum et al.,
2014; Rhoads and Au, 2015; Rand et al., 2017; Simpson et al.,
2017).
Protein Binding Profiles of Novel
Modifications and Epigenetic Manipulation
With the identification and characterisation of potential
DNA modifiers and binding proteins, mechanisms for the
remodeling and maintenance of novel modifications can
be further investigated and thereby provide clues about
their regulatory role and biological significance during early
development. Modulation of expression of DNA modification-
binding proteins are currently used for altering certain DNA
modifications in vivo. However, these strategies cannot provide
region-specific or subtle epigenetic changes which can be
‘matched’ with observed phenotype(s). With a comprehensive
understanding of DNA modification-interacting proteins
and CRISPR-related techniques, novel tools that allow
epigenetic manipulation at a specific genomic region will
provide direct evidence for correlations or causality between
distinct epigenetic modifications and specific biological events,
such as transgenerational epigenetic inheritance of disease risks
(Magnani, 2014). Manipulation tools for several well-studied
epigenetic modifications have already been applied (Liu X. S.
et al., 2016; Thakore et al., 2016).
“Rediscover” DNA Modifications and the
Relationship With RNA Modifications
The discovery of 6mA in eukaryotic genomes makes it tempting
to speculate that the existence of DNA modifications in
eukaryotic genomes is much more diverse than previously
thought. Some DNA modifications detected at levels comparable
to 5fC and 5caC were considered as well-established DNA lesions
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FIGURE 1 | DNA methylation in the mammalian lifecycle DNA methylation profiles show differences in the lifecycle of different mammals. They are most dynamic
during the epigenetic reprogramming in preimplantation embryo and primordial germ cells (PGCs). 5mC is largely erased during both epigenetic reprogramming
events in the pre-implantation embryo and germ cells and subsequently re-established. Methylation reprogramming in PGCs is more extensive than in early embryo,
including demethylation of imprinted genes and repetitive elements. 5hmC, 5fC and 5caC are the oxidized products of TET-mediated active demethylation. Timing and
extent of TET-mediated active demethylation differ between genders in pre-implantation embryos and in PGCs of different species. 6mA is found enriched in pig
oocytes and early embryos. The epigenome is much more vulnerable to environmental influences, especially during the extensive remodeling phases, which may lead
to abnormal epigenetic states in the embryo and germline that contribute to future development and inheritance of disease.
and therefore rarely investigated for biological significance.
Recent studies suggest, other than causing genetic mutations,
some of the rare DNA modifications may have biological
functions via BER pathways, thereby representing a blur between
DNA damage and epigenetic markers (Robertson et al., 2014;
Ding et al., 2017; Fleming and Burrows, 2017).
On the other hand, modifications previously only in
prokaryotic genomes or on RNA may be potential candidates
for hitherto overlooked modifications in mammalian genomes.
Some modifications and their binding proteins are ‘shared’
between DNA and RNA (Hudson and Ortlund, 2014). Similar
to 6mA and its suggested modifier FTO, 5hmC, 5fC, and 5caC
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modification are also detected on RNA in mammals. Indeed,
the latter mentioned RNA modifications have been suggested
to be mediated by TET1 (Zhang H. Y. et al., 2016; Basanta-
Sanchez et al., 2017). It would be of interest to identify the
differences between DNA/RNA modifiers within a family that
have significant preference towards DNA or RNA for further
understanding of their functions and evolution. It is possible
that during evolution these modifiers have shifted specificity
from one type of nucleic acid to another, or lost their ‘dual’
specificity. Their ancient activities may not exist in vivo but might
be observed in in vitro assays (Forterre and Grosjean, 2013).
RNA modifications may also be of great interest as
they regulate RNA metabolism and gene expression at the
translational level. RNA modifications and small non-coding
RNAs are potential mediators of epigenetic inheritance in
mammals. Recent reports indicate that malnutrition (Chen et al.,
2016a; Sharma et al., 2016), stress/trauma (Gapp et al., 2014a;
Rodgers et al., 2015) or exposure to toxins (Schuster et al., 2016)
can lead to epigenetic inheritance mediated via small non-coding
RNA in the male germline (Chen et al., 2016a; Watson, 2016).
Elevated levels of 5-methylcytosine of RNA (m5C), which has
been linked with increased stability of tRNA (Schaefer et al., 2010;
Tuorto et al., 2012; Kiani et al., 2013), and N2-methylguanosine
of RNA (m2G) have both been observed on small RNAs in sperm
from mice fed high fat diets (HFD); this apparently is linked
with the transmission of metabolic disorders to offspring (Chen
et al., 2016a). That is, RNA modifications could contribute to the
transmission of metabolic disorder via sperm small RNAs (Chen
et al., 2016,b).
Interplay and Cooperation Within the
Epigenome
The relative instability of RNA makes it unlikely to mediate
epigenetic inheritance on its own. The interplay and cooperation
among different epigenetic markers, which are still largely
unclear, are likely to be critical for modulating biological events
such as epigenetic inheritance and early embryonic development
as well as for maintaining genome stability and cell identity
during epigenetic reprogramming. A recent study of vinclozolin-
induced transgenerational epigenetic inheritance indicates such
association between differential methylated regions (DMRs) in
F3 male germline, as early as E13, with sperm-borne small
non-coding RNA (sncRNA) expression (Schuster et al., 2016).
Co-existence of epigenetic modifications often indicate such
cooperation within the epigenome and may reveal potential
functions of novel DNA modifications. As mentioned above,
apart from the correlation between 5mC and multiple histone
modifications (Cedar and Bergman, 2009; Rose and Klose, 2014),
5hmC, 5fC, 5caC, and 6mA have also been reported to co-exist
with certain histone modifications. New methods will be needed
to detect multiple epigenetic modifications in the same context at
individual loci within individual cells.
With more epigenetic modifications being discovered which
can be highly dynamic, it will be necessary to establish databases
curated for such information. Strides towards such goals are
already in process. Recently, a manually curated database
for epigenetic modifications during gametogenesis in seven
mammals has been reported (Bai et al., 2017). Linkage between
epigenetic modification databases with other databases such
as interaction databases, pathway databases and disease-related
databases would also be useful.
In summary, discovery and characterisation of novel
DNA modifications are fascinating and fast-moving fields.
DNA modifications often display extraordinarily dynamic
patterns during early embryonic and germline development,
yet the cause and consequence of these phenomena remain
unclear. Therefore, exploring the dynamics of novel DNA
modification during early development is a necessity for further
understanding of DNA modifications in different biological
contexts and a comprehensive epigenome map of mammalian
genome.
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